Clinical study of unani compound formulation in treatment of kidney stones.
Phase 2
- Conditions
- Health Condition 1: N200- Calculus of kidney
- Registration Number
- CTRI/2022/01/039603
- Lead Sponsor
- Central Council of Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically/ radiologically diagnosed patients of Hasah-e-Kulya (Nephrolithiasis) from size 5 to 10mm.
Patients irrespective of gender.
Patients between 18 to 60 years of age.
Patients who are agreed to sign the informed consent form and follow the protocol.
Exclusion Criteria
Pregnant and lactating women
Patients below the age of 18 years and above the age of 60 years.
Diabetes Mellitus.
Hydronephrosis grade II and above
Poorly controlled Hypertension.
Significant Liver and Renal dysfunction.
Cardiovascular diseases.
Unwillingness or inability to sign consent form.
A medical condition that in the investigatorâ??s opinion would interfere the treatment, safety or adherence to protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relief in signs and symptoms of nephrolithiasisTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Haematological, radiological and biochemical assesmentTimepoint: 45 days